FDA Import Refusal AEK-7541596-6/10002/1 — BOEHRINGER INGELHEIM INDIA PVT
The FDA refused shipment AEK-7541596-6/10002/1 from BOEHRINGER INGELHEIM INDIA PVT (India) on Sep 17, 2025. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 17, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75